Search

everythinglearnresearchcommunity

for

Search:↓

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Artesunate is generally safe for severe malaria, but patients should be monitored for delayed anemia after treatment.

Severe digestive issues in DRESS need early endoscopy for better treatment.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Early treatment of superficial fungal infections in immunocompromised patients is crucial.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Psychiatrists are crucial in pain management teams because they help treat severe pain and related mental health issues.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

During the COVID-19 pandemic in Turkey, the most common skin problem for both kids and adults was acne.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Covid-19 can cause hair loss due to immune and psychological factors.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

The document concludes that early diagnosis and treatment are crucial for children with hair loss to prevent permanent damage, although not all conditions can be effectively treated.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

The document concludes that various disorders can cause hair loss in dogs, each requiring different treatments, and some may heal on their own.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Biotin treatment can significantly improve hair loss and motor functions in certain metabolic disorders.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.